SMC accepted sitagliptin to treat type-2 diabetes in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate control of blood sugar.
It also accepted it for use in combination with a sulphonylurea when diet and exercise plus the highest tolerated dose of sulphonylurea does not provide adequate control of blood sugar and when metformin is not suitable.
The SMC noted that, although sitagliptin is also licensed for use in combination with thiazolidinedione drugs, the manufacturer’s submission related only to the use of sitagliptin in combination with sulphonylureas with or without metformin.
The SMC said it therefore could not recommend the use of sitagliptin in combination with thiazolidinediones.
tom.moberly@haymarket.com
Comment below and tell us what you think
Quick search - use * for an abbreviated search, eg nico*
Health professionals can help patients recover from psychosexual trauma, writes Graham Wilmer. Read More
As the new 'super-surgeries' open, we consider the possible opportunities for nurses. Joe Lepper rep... Read More
Daniel Brown, Roehampton, London Read More
Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more
Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more
Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more
Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more
Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more
Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more
This site is intended for healthcare professionals only
I am already registered and would like to log in.
I would like to register on Healthcare Republic.
If you have any issues, please contact Healthcare Republic.
Comments
Only registered users may comment. Log in now or register for a free account.
There are problems with your form submission.
Please review the errors shown below.